Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)

Hangzhou Alltest Biotech Revenue

Hangzhou Alltest Biotech had revenue of 196.77M CNY in the quarter ending June 30, 2026, a decrease of -11.11%. This brings the company's total for the last twelve months to 867.64M, down -3.59% year-over-year. In the year 2025, Hangzhou Alltest Biotech had annual revenue of 905.34M with 4.47% growth. That makes Hangzhou Alltest Biotech the 20,690th largest company in the world by revenue and 3,790th in China.

• Revenue (ttm): 867.64M
• Revenue Growth: -3.59%
• P/S Ratio: 3.86
• Revenue / Employee: 903.79K
• Employees: 960
• Market Cap: 3.39B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Overseas 836.44M 93.0%
• China 63.01M 7.0%

Fiscal year ended Dec 31, 2025 See the full Hangzhou Alltest Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	905.34M	38.76M	4.47%
Dec 31, 2024	866.58M	111.89M	14.83%
Dec 31, 2023	754.70M	-2.63B	-77.73%
Dec 31, 2022	3.39B	1.52B	80.88%
Dec 31, 2021	1.87B	737.87M	64.98%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error